Drug Shortage Report for TARO-VENLAFAXINE XR
Report ID | 11207 |
Drug Identification Number | 02380072 |
Brand name | RAN-VENLAFAXINE XR |
Common or Proper name | RAN-VENLAFAXINE XR |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 37.5MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-11-28 |
Actual start date | 2018-11-28 |
Estimated end date | 2019-06-28 |
Actual end date | 2019-07-05 |
Shortage status | Resolved |
Updated date | 2019-07-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.